Drugs for Human Immunodeficiency Virus Infectious Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 808)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Lercanidipine |
Approved, Investigational |
Phase 4 |
|
100427-26-7 |
65866 |
Synonyms:
Biohorm brand OF lercanidipine hydrochloride
Lercadip
LERCANIDIPINE
Lercanidipine hydrochloride
Lercanidipino
|
Lercanil
Lerdip
Methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Zanidip
|
|
2 |
|
Candesartan cilexetil |
Approved |
Phase 4 |
|
145040-37-5 |
|
Synonyms:
1-(Cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
Amias
Atacand
Blopress
CANDESARTAN
|
Candesartan cilexetil
Kenzen
Parapres
RATACAND
TCV 116
TCV-116
|
|
3 |
|
Zalcitabine |
Approved, Investigational |
Phase 4 |
|
7481-89-2 |
24066 |
Synonyms:
2',3' Dideoxycytidine
2',3'-Dideoxycytidine
4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)-2-TETRAHYDROFURANYL]-2-PYRIMIDINONE
4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]PYRIMIDIN-2-ONE
4-Amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]PYRIMIDIN-2-ONE
4-AMINO-1-[(2R,5S)-5-METHYLOLTETRAHYDROFURAN-2-YL]PYRIMIDIN-2-ONE
4-AZANYL-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]PYRIMIDIN-2-ONE
DDC
DDC (Antiviral)
DDCYD
|
Dideoxycytidine
DIDEOXYCYTIDINE (DDC)
Hivid
HIVID roche
Hoffman-la roche brand OF zalcitabine
NSC-606170
RO-242027000
RO-24-2027000
RO-242027000/RO-24-2027-000
Roche brand OF zalcitabine
ZALCITABINE
|
|
4 |
|
Didanosine |
Approved |
Phase 4 |
|
69655-05-6 |
50599 |
Synonyms:
2',3' Dideoxyinosine
2,3-Dideoxyinosine
2',3'-Dideoxyinosine
9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one
9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one
9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol
9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one
ABBR ddi
BMY-40900
Bristol myers brand OF didanosine
Bristol myers squibb brand OF didanosine
Bristol-myers brand OF didanosine
Bristol-myers squibb brand OF didanosine
|
DDI
DdI (antiviral)
DdIno
Didanosina
Didanosine
DIDANOSINE SYSTEM SUITABILITY MIXTURE
Didanosinum
Dideoxyinosine
DIDEOXYINOSINE (DDI)
NSC-612049
Videx
VIDEX EC
|
|
5 |
|
Buprenorphine |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
52485-79-7, 53152-21-9 |
644073 40400 |
Synonyms:
(−)-buprenorphine
(-)-Buprenorphine
17-Cyclopropylmethyl-4,5a-epoxy-7a-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
2-(N-Cyclopropylmethyl-4,5a-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6a-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol
2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
21-Cyclopropyl-7a-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
ALKS-5461 COMPONENT BUPRENORPHINE
BUPEAZE
BUPLAST
Buprel
Buprenex
Buprenex®|Buvidal®|CAM2038|Sixmo® (buprenorphine hydrochloride)|Subutex®|Temgesic®
Buprenophine
Buprenorfina
Buprenorfina [INN-Spanish]
BUPRENORPHINE
Buprenorphine grünenthal brand
Buprenorphine Hcl
Buprenorphine hydrochloride
Buprenorphinum
Buprenorphinum [INN-Latin]
Buprex
|
BUTEC
BUTRANS
Essex brand OF buprenorphine hydrochloride
Grünenthal brand OF buprenorphine
Grünenthal brand OF buprenorphine hydrochloride
HAPOCTASIN
Hydrochloride, buprenorphine
Key brand OF buprenorphine hydrochloride
PANITAZ
Prefin
PRENOTRIX
Probuphine
Reckitt and colman brand 1 OF buprenorphine hydrochloride
Reckitt and colman brand 2 OF buprenorphine hydrochloride
Reckitt benckiser brand OF buprenorphine hydrochloride
Reckitt brand OF buprenorphine hydrochloride
RELETRANS
RX 6029 m
RX-6029-m
Schering plough brand OF buprenorphine hydrochloride
Schering-plough brand OF buprenorphine hydrochloride
SEVODYNE
SUBLOCADE
Subutex
Temgesic
Temgésic
TEPHINE
TRANSTEC
|
|
6 |
|
Trimethoprim |
Approved, Vet_approved |
Phase 4 |
|
738-70-5 |
5578 |
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
BW-5672
BW-56-72
CO-Trimoxazole
IPRAL
LEDATRIM
MONOTRIM
NIH-204
NSC-106568
POLYTRIM
PRIMSOL
Proloprim
PROLOPRIN
|
SYRAPRIM
TCMDC-125538
TIEMPE
TMP
TRIMETHOPRIM
TRIMETHOPRIME
TRIMÉTHOPRIME
TRIMETHOPRIMUM
TRIMETOPRIMA
TRIMOGAL
TRIMOPAN
Trimpex
TRIMPEX 200
TRIPRIMIX 200
|
|
7 |
|
Sulfamethoxazole |
Approved |
Phase 4 |
|
723-46-6 |
5329 |
Synonyms:
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulphonamido)-5-methylisoxazole
3-(Para-aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulphonamide
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
ACETYLSULFAMETHOXAZOLE
Apo-Sulfamethoxazole
Azo Gantanol
Azo-gantanol
Bactrim
Bactrimel
Gamazole
Gantanol
GANTANOL (TN)
GANTANOL-DS
Metoxal
N'-(5-methyl-3-isoxazole)sulfanilamide
N'-(5-methyl-3-isoxazolyl)sulfanilamide
N'-(5-methyl-3-isoxazolyl)-sulfanilamide
N'-(5-methylisoxazol-3-yl)sulphanilamide
N^1-(5-methyl-3-isoxazolyl)-sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)-sulfanilamide
|
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-sulfanilamide
NSC-147832
Radonil
RO-42130
RO-4-2130
Septran
SIM
Simsinomin
Sinomin
SMX
SMZ
STX-608
Sulfamethalazole
Sulfamethoxazol
SULFAMETHOXAZOLE
SULFAMETHOXAZOLE SODIUM
Sulfamethoxazole(usan)
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfisomezole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulpha-methoxizole
Sulphamethylisoxazole
Sulphisomezole
SUPHAMETHOXAZOLE
Trib
UROBAK
|
|
8 |
|
Lopinavir |
Approved |
Phase 4 |
|
192725-17-0 |
92727 |
Synonyms:
378, ABT
A-157378.0
A-157378-0
ABT 378
ABT-378
ABT-378a-157378-0a-157378.0
Aluviran
Kaletra
|
Koletra
LOPINAVIR
LPV
N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
SID124893167
SID144205757
SID50111692
|
|
9 |
|
Entecavir |
Approved, Investigational |
Phase 4 |
|
142217-69-4 |
153941 |
Synonyms:
ANHYDROUS ENTECAVIR
Baraclude
BMS-200475-01
Entecavir
ENTECAVIR (ANHYDROUS)
|
ENTECAVIR ANHYDROUS
ENTECAVIR HYDRATE
ENTECAVIR MONOHYDRATE
ENTECAVIRUM
SQ-34676
|
|
10 |
|
Megestrol acetate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
595-33-5 |
11683 |
Synonyms:
17-ACETOXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE
17ALPHA-ACETOXY-6-DEHYDRO-6-METHYLPROGESTERONE
17ALPHA-HYDROXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE ACETATE
17-HYDROXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE 17-ACETATE
17Α-ACETOXY-6-DEHYDRO-6-METHYLPROGESTERONE
17Α-HYDROXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE ACETATE
5071
6-DEHYDRO-6-METHYL-17ALPHA-ACETOXYPROGESTERONE
6-DEHYDRO-6-METHYL-17Α-ACETOXYPROGESTERONE
6-METHYL-17ALPHA-ACETOXYPREGNA-4,6-DIENE-3,20-DIONE
6-METHYL-17ALPHA-HYDROXY-DELTA(SUP 6)-PROGESTERONE ACETATE
6-METHYL-17Α-ACETOXYPREGNA-4,6-DIENE-3,20-DIONE
6-METHYL-17Α-HYDROXY-DELTA(SUP 6)-PROGESTERONE ACETATE
6-METHYL-6-DEHYDRO-17ALPHA-ACETOXYPROGESTERONE
6-METHYL-6-DEHYDRO-17Α-ACETOXYPROGESTERONE
6-METHYL-DELTA(SUP 4,6)-PREGNADIEN-17ALPHA-OL-3,20-DIONE ACETATE
6-METHYL-DELTA(SUP 4,6)-PREGNADIEN-17Α-OL-3,20-DIONE ACETATE
6-METHYL-DELTA(SUP 6)-DEHYDRO-17ALPHA-ACETOXYPROGESTERONE
6-METHYL-DELTA(SUP 6)-DEHYDRO-17Α-ACETOXYPROGESTERONE
|
BDH-1298
MAGESTIN
MAYGACE
MEGACE
MEGACE ES
MEGERON
MEGESTAT
MEGESTIL
MEGESTIN
MEGESTROL
MEGESTROL ACETATE
MGA
NIA
NIAGESTIN
NSC-71423
OVABAN
OVARID
SC-10363
VOLIDAN
|
|
11 |
|
Mupirocin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
12650-69-0 |
446596 |
Synonyms:
14C-Labeled mupirocin
9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3- [(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2-YL]METHYL] OXAN-2-YL]-3-METHYLBUT-2-ENOYL]OXYNONANOIC ACID
Acid, pseudomonic
Bactroban
BRL 4910a
BRL-4910a
Centany
MRC
MUP
MUPIROCIN
Mupirocin calcium
Mupirocin, 14C labeled
|
Mupirocin, 14C-labeled
Mupirocin, calcium salt (2:1)
Mupirocin, calcium salt (2:1), dihydrate
Mupirocin, lithium salt
Mupirocin, sodium salt
Mupirocina
Mupirocine
Mupirocinum
Pseudomonate a
Pseudomonic acid
Pseudomonic acid a
|
|
12 |
|
Elvitegravir |
Approved |
Phase 4 |
|
697761-98-1 |
23083982 5277135 |
Synonyms:
6-(3-CHLORO-2-FLUOROBENZYL)-1-[(2S)-1-HYDROXY-3-METHYLBUTAN-2-YL]-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
ABBR evg
ELVITEGRAVIR
ELVITÉGRAVIR
EVG
|
GS 9137
GS-9137
JTK-303
Vitekta
|
|
13 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 4 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Β-HYDROXYAMPHETAMINE
|
|
14 |
|
Methadone |
Approved |
Phase 4 |
|
76-99-3, 1095-90-5 |
4095 |
Synonyms:
(±)-methadone|dl-methadone|Dolophine HCL®|methadone HCl|Methadose®
(+-)-Methadone
(+/-)-methadone
(+/-)-methadone hydrochloride
(±)-methadone
6-(Dimethylamino)-4,4-diphenyl-3-heptanone
6-dimethylamino-4,4-Diphenyl-3-heptanone
Adanon
Adanon hydrochloride
AddiCare brand OF methadone hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose hydrochloride
Amidon
Amidone
Biodone
Biomet brand OF methadone hydrochloride
Biscuits
Butalgin
Depridol
Diaminon
Diaminon hydrochloride
DL-Methadone
DL-Methadone hydrochloride
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine HCL
Esteve brand OF methadone hydrochloride
Fenadon
Fenadone
Generics brand OF methadone hydrochloride
GlaxoSmithKline brand OF methadone hydrochloride
HEPTADON
Heptadone
|
Heptanon
Hydrochloride, methadone
IDS-NM-002
Ketalgin
Ketalgin hydrochloride
Mallinckrodt brand OF methadone hydrochloride
Martindale brand OF methadone hydrochloride
Mecodin
Mephenon
Metadol
Metadona
Metasedin
Methaddict
Methadon
METHADONE
Methadone HCL
Methadone HCL Intensol
Methadone hydrochloride
Methadone M
Methadonum
Methadose
Methaquaione
Methex
Miadone
Moheptan
Pharmascience brand OF methadone hydrochloride
Phenadone
Phenadone hydrochloride
PHY
Phymet
Physeptone
Pinadone
Pinewood brand OF methadone hydrochloride
Polamidon
Polamidone
Rosemont brand OF methadone hydrochloride
Roxane brand OF methadone hydrochloride
Symoron
Tussol
WESTADONE
Yamanouchi brand OF methadone hydrochloride
|
|
15 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
16 |
|
Midazolam |
Approved, Illicit |
Phase 4 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
17 |
|
Indinavir |
Approved |
Phase 4 |
|
150378-17-9 |
5362440 |
Synonyms:
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide
Compound J
Crixivan
INDINAVIR
INDINAVIR ANHYDROUS
INDINAVIR MONOHYDRATE
Indinavir sulfate
|
Indinavir sulphate
INDINAVIR SYSTEM SUITABILITY
Indinavir, sulfate (1:1)
L-735524
MK-639
Sulfate, indinavir
|
|
18 |
|
Stavudine |
Approved, Investigational |
Phase 4 |
|
3056-17-5 |
18283 |
Synonyms:
1-(2,3-Dideoxy-b-D-glycero-pent-2-enofuranosyl)thymine
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine
1-(2,3-Dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine
2',3' Didehydro 3' deoxythymidine
2',3'-Didehydro-2',3'-dideoxythmidine
2',3'-Didehydro-3'-deoxythimidine
2',3'-Didehydro-3'-deoxythymidine
3'-Deoxy-2'-thymidinene
ABBR D4T
BMY-27857
Bristol-myers brand OF stavudine
Bristol-myers squibb brand OF stavudine
d4T
D-4T
|
Estavudina
Estavudina [INN-Spanish]
NSC-163661
Sanilvudine
STAVUDIN
STAVUDINE
Stavudine [Usan:Ban:Inn]
Stavudine, monosodium salt
Stavudinum
Stavudinum [INN-Latin]
STV
Zerit
ZERIT XR
Zerut XR
|
|
19 |
|
Fosamprenavir |
Approved |
Phase 4 |
|
226700-79-4 |
131536 |
Synonyms:
(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester
Fos-amprenavir
FOSAMPRENAVIR
Fosamprenavir calcium
FOS-apv
GW433908
|
GW-433908
GW433908A
GW908 CPD
Lexiva
Telzir
VX175 CPD
|
|
20 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 4 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
21 |
|
Pioglitazone |
Approved, Investigational |
Phase 4 |
|
111025-46-8 |
4829 |
Synonyms:
(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(±)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
5-{4-[2-(5-ETHYLPYRIDIN-2-YL)ETHOXY]BENZYL}-1,3-THIAZOLIDINE-2,4-DIONE
Actos
Actos®|Glustin®|pioglitazone HCl|U-72107A
Actost
AD-4833
DUETACT
Glustin
Pioglitazona
Pioglitazona [INN-Spanish]
|
PIOGLITAZONE
Pioglitazone [Ban:Inn]
Pioglitazone HCL
Pioglitazone hydrochloride
Pioglitazonum
Pioglitazonum [INN-Latin]
Poglitazone hydrochloride
U-72107
U-72107A
XAB907
ZACTOS
|
|
22 |
|
Pravastatin |
Approved |
Phase 4 |
|
81093-37-0 |
54687 |
Synonyms:
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoate
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid
(3R,5R)-7-[(1S,2S,6S,8S,8AR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
3beta-Hydroxycompactin
Apo pravastatin
Apo-pravastatin
Apotex brand OF pravastatin sodium
Aventis brand OF pravastatin sodium
Bristacol
Bristol-myers squibb brand OF pravastatin sodium
C10AA03
Compactin
Elisor
Eptastatin
Esteve brand OF pravastatin sodium
Juste brand OF pravastatin sodium
Lin pravastatin
Lin-pravastatin
Linson pharma brand OF pravastatin sodium
Lipemol
Liplat
Lipostat
Lipostat®|Pravachol®|pravastatin sodium
Mevalothin
Mevalotin
Mevastatin
Mevinolin
Nu pravastatin
Nu-pharma brand OF pravastatin sodium
Nu-pravastatin
|
Oliprevin
Prareduct
Pravachol
Pravacol
Pravaselect
Pravasin
PRAVASTATIN
Pravastatin acid
Pravastatin monosodium salt, (6 beta)-isomer
Pravastatin sodium
Pravastatin sodium salt
Pravastatin tert octylamine salt
Pravastatin tert-octylamine salt
Pravastatin, (6 beta)-isomer
Pravastatina
Pravastatina [Spanish]
Pravastatine
Pravastatine [French]
Pravastatinum
Pravastatinum [Latin]
Pravator
RMS 431
RMS-431
Sankyo brand OF pravastatin sodium
Selectin
Selektine
Selipran
Sodium salt, pravastatin
Squibb brand OF pravastatin sodium
Vasten
|
|
23 |
|
Vincristine |
Approved, Investigational |
Phase 4 |
|
2068-78-2, 57-22-7 |
5978 |
Synonyms:
(+)-Vincristine
22-OXOVINCALEUKOBLASTIN
22-oxo-Vincaleukoblastine
22-Oxovincaleukoblastine
22-oxovincaleukoblastine|kyocristine|leurocristine sulfate|NSC-67574|Oncovin®
37231
Cellcristin
Citomid
Farmistin
Indole alkaloid
KYOCRISTINE
LCR
Leucristine
Leurocristine
LEUROCRISTINE SULFATE
LILLY-37231
Marqibo
MARQIBO KIT
NSC-67574
Onco TCS
Oncovin
Oncovine
Onkocristin
PFS, Vincasar
|
Sulfate, vincristine
Tecnocris
VCR
VIN
Vincasar
Vincasar PFS
VINCREX
Vincristin
Vincristin bristol
Vincristin medac
Vincristina
Vincristina [DCIT]
VINCRISTINE
Vincristine sulfate
VINCRISTINE SULFATE PFS
VINCRISTINUM
Vincristinum [INN-Latin]
Vincrisul
Vincrstine
Vincrystine
Vinkristin
Vintec
Z-D-Val-lys(Z)-OH
|
|
24 |
|
Zoledronic acid |
Approved |
Phase 4 |
|
118072-93-8 |
68740 |
Synonyms:
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonate
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonate
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
ácido zoledrónico
ACLASTA
Aclasta®|CGP-42446|CGP-42446A|Reclast®|zoledronate|Zometa®
ANHYDROUS ZOLEDRONIC ACID
CGP-42446
CGP-42446A
Novartis brand OF zoledronic acid
|
Reclast
ZERLINDA
ZOL
ZOL446
ZOLEDRONATE
Zoledronic acid
Zoledronic acid anhydrous
ZOLEDRONIC ACID HYDRATE
ZOLEDRONIC ACID MONOHYDRATE
ZOLEDRONIC ACID, ANHYDROUS
Zometa
Zometa Concentrate
|
|
25 |
|
Lactitol |
Approved, Investigational |
Phase 4 |
|
585-86-4 |
157355 |
Synonyms:
4-O-beta-D-Galactopyranosyl-D-glucitol
4-O-β-D-Galactopyranosyl-D-glucitol
D-Lactitol
Emportal
Importal
Lactitol
|
Lactitolum
Neda lactiv importal
Oponaf
Pizensy
WURCS=2.0/2,2,1/[H2122H][a2112h-1b_1-5]/1-2/a4-b1
|
|
26 |
|
Zinc cation |
Approved, Experimental, Investigational |
Phase 4 |
|
7440-66-6, 23713-49-7 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
Mannosidase b, alpha
Neutral alpha mannosidase
|
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc ion(2+)
Zinc(2+)
Zinc(II)
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
zinc|zinc ion
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
27 |
|
Zinc sulfate |
Approved, Investigational |
Phase 4 |
|
7733-02-0 |
|
Synonyms:
Zinc sulfate (anhydrous)
Zinc sulfate anhydrous
Zinc sulfate, anhydrous
|
Zinc sulphate
Zinc sulphate anhydrous
Zinc sulphate, anhydrous
|
|
28 |
|
Atovaquone |
Approved |
Phase 4 |
|
95233-18-4 |
74989 |
Synonyms:
2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
566C
566C80
Acuvel
|
Atovacuona
ATOVAQUONE
Mepron
Wellvone
|
|
29 |
|
Proguanil |
Approved |
Phase 4 |
|
500-92-5 |
4923 6178111 |
Synonyms:
1-(p-Chlorophenyl)-5-isopropylbiguanide
Chlorguanide
Chloroguanide
N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide
|
PROGUANIL
Proguanile
Proguanilo
Proguanilum
|
|
30 |
|
Sofosbuvir |
Approved |
Phase 4 |
|
1190307-88-0 |
45375808 |
Synonyms:
GI 7977
GI-7977
GS7977
GS-7977
ISOPROPYL (2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL]METHOXY}(PHENOXY)PHOSPHORYL]AMINO}PROPANOATE
PSI 7977
|
PSI-7977
PSI-7977, GS-7977
S)-ISOPROPYL 2-((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)- (PHENOXY)PHOSPHORYLAMINO)PROPANOATE
SOFOSBUVIR
SOVALDI
|
|
31 |
|
Famotidine |
Approved |
Phase 4 |
|
76824-35-6 |
3325 5702160 |
Synonyms:
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulphamide
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulphonyl)propanimidamide
3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine
3-{[(2-CARBAMIMIDAMIDO-1,3-THIAZOL-4-YL)METHYL]SULFANYL}-N-SULFAMOYLPROPANIMIDAMIDE
Amfamox
Antodine
Apo-famotidine
Apogastine
Bestidine
Blocacid
Brolin
Cepal
Confobos
Cronol
Cuantin
Famocid
Famodar
Famodil
Famodin
Famodine
Famogard
Famonit
Famopsin
Famos
Famosan
Famotal
Famotep
Famotidina
Famotidine
Famotidine hydrochloride
FAMOTIDINE PRESERVATIVE FREE
Famotidinum
Famotin
Famovane
Famowal
Fluxid
GASTER
Gaster®|MK-208|Pepcid®
Gastridan
Gastridin
Gastrion
Gastro
Gastrodomina
Gastrofam
Gastropen
Gastrosidin
Hacip
Huberdina
Ingastri
Invigan
|
L 643341
Lecedil
Logos
Mensoma
Midefam
MK-208
Mosul
Motiax
Muclox
Mylanta ar
Neocidine
Nevofam
Notidin
Novo-famotidine
N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
N-Sulphamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
Nulceran
Nulcerin
Panalba
Pepcid
PEPCID AC
PEPCID PRESERVATIVE FREE
PEPCID RPD
Pepcidin
Pepcidin pepcidine
PEPCIDIN PEPCIDINE
Pepdine
Pepdul
Pepfamin
Peptan
Peptidin
Purifam
Quamatel
Quamtel
Renapepsa
Restadin
Rogasti
Rubacina
Tamin
Tipodex
Topcid
Ulcatif
Ulceprax
Ulcofam
Ulfagel
Ulfam
Ulfamid
Ulfinol
Ulgarine
Vagostal
YM-11170
|
|
32 |
|
Artenimol |
Approved, Experimental, Investigational |
Phase 4 |
|
71939-50-9 |
540327 |
Synonyms:
3alpha-Hydroxydeoxydihydroartemisinin
8alpha-Hydroxydeoxyartemisinin
9alpha-Hydroxydeoxyartemisinin
ARTEMETHER RELATED COMPOUND A
ARTENIMOL
beta-Dihydroartemisinin
DIHYDROARTEMISININ
|
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12alpha,12ar*))-isomer
Dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12ar*))-isomer
GNF-PF-5634
|
|
33 |
|
Piperaquine |
Approved, Experimental, Investigational |
Phase 4 |
|
4085-31-8 |
|
Synonyms:
1,3-Bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-Bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
1,3-Bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane
|
PIPERAQUINE
Piperaquinoline
|
|
34 |
|
Pyrimethamine |
Approved, Investigational, Vet_approved |
Phase 4 |
|
58-14-0, 19085-09-7 |
4993 |
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
Aventis brand OF pyrimethamine
CD
Chloridin
Chloridine
Chloridyn
Darachlor
Daraclor
Darapram
Daraprim
Daraprim®|GNF-Pf-5586|TCMDC-125860
Daraprime
Diaminopyritamin
Disulone
Erbaprelina
Ethylpyrimidine
Fansidar
Glaxo wellcome brand OF pyrimethamine
GlaxoSmithKline brand OF pyrimethamine
GNF-PF-5586
|
Khloridin
Malacid
MALACIDE
Malocid
Malocide
Maloprim
NSC-3061
Pirimecidan
Pirimetamin
Pirimetamina
Primethamine
Pyremethamine
Pyrimethamin
PYRIMETHAMINE
Pyriméthamine
Pyrimethamine Hcl
Pyrimethaminum
RP-4753
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
Wellcome brand OF pyrimethamine
WR-2978
|
|
35 |
|
Sulfadoxine |
Approved, Investigational |
Phase 4 |
|
2447-57-6 |
17134 |
Synonyms:
4-Sulfanilamido-5,6-dimethoxypyrimidine
4-Sulphanilamido-5,6-dimethoxypyrimidine
Fanasil
FANZIL
J21.373J
RO-44393
RO-4-4393
Roche brand OF sulfadoxine
Sulfadoxina
SULFADOXINE
Sulfadoxine roche brand
Sulfadoxinum
|
Sulformethoxine
Sulformetoxine
SULFORTHAMIDINE
Sulforthomidine
Sulphadoxina
Sulphadoxine
Sulphadoxinum
Sulphormethoxine
Sulphormetoxin
Sulphorthodimethoxine
Sulphorthomidine
WR-4073
|
|
36 |
|
Modafinil |
Approved, Investigational |
Phase 4 |
|
68693-11-8 |
4236 |
Synonyms:
2-((Diphenylmethyl)sulfinyl)acetamide
2-((R)-(Diphenylmethyl)sulfinyl)acetamide
2-[(Diphenylmethyl)sulphinyl]acetamide
Alertec
Armodafinil
Benzhydrylsulfinylacetamide
CEP-1538
CEPA brand OF modafinil
Cephalon brand OF modafinil
Cephalon brand OF modafinil, reformulated
CRC-40476
CRL-40476
Dea No. 1680
DEP-1538
Draxis brand OF modafinil
Lafon brand OF modafinil
Merckle brand OF modafinil
Modafinil
|
Modafinil [Usan:Inn]
MODAFINIL CIV
Modafinilo
Modafinilo [Spanish]
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Nourypharma brand OF modafinil
Nuvigil
Provigil
Provigil®
R Modafinil
R-Modafinil
Sparlon
THN102 COMPONENT MODAFINIL
THN-102 COMPONENT MODAFINIL
Vigil
|
|
37 |
|
Hydrocortisone succinate |
Approved |
Phase 4 |
|
2203-97-6 |
3643 |
Synonyms:
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
Cortisol 21-(hydrogen succinate)
Cortisol succinate
HYDROCORTISONE HEMISUCCINATE
|
Hydrocortisone hemisuccinate anhydrous
Hydrocortisone hydrogen succinate
HYDROCORTISONE SUCCINATE
Hydroxycortisone succinate
NSC-7576
|
|
38 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 4 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
BARQUINOL HC
CHLOROMYCETIN HYDROCORT
COLIFOAM
CORTEF ACETATE
CORTIFOAM
Cortisol 21-acetate
CORTRIL
CORTUCID
DRICORT
EPIFOAM
FRAMYCORT
FUCIDIN H
GENTICIN HC
GENTISONE HC
|
GPPE EAR SUSP
GPPE EYE CRM
GPPE FOAM AERO
HC45 HYDROCORT
HEMSOL-HC
HEPACORT PLUS
HYDROCAL
HYDROCORTISONE 21-ACETATE
HYDROCORTISONE ACETATE
HYDROCORTONE
LANACORT
MICORT-HC
NEO-CORTEF
NSC-741
ORABASE HCA
|
|
39 |
|
Hydrocortisone |
Approved, Vet_approved |
Phase 4 |
|
50-23-7 |
3640 5754 |
Synonyms:
(11ALPHA,14BETA)-11,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE
(11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11Β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(1S,2R,10S,11S,14S,15S,17S)-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
11 Epicortisol
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b,17a,21-Trihydroxy-4-pregnene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11-beta-Hydrocortisone
11beta-Hydroxycortisone
11-beta-Hydroxycortisone
11b-Hydrocortisone
11b-Hydroxycortisone
11-Epicortisol
11-Hydrocortisone
11Β,17α,21-trihydroxy-4-pregnene-3,20-dione
11Β-hydrocortisone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
17-Hydroxycorticosterone
4-Pregnen-11b,17a,21-triol-3,20-dione
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnen-11β,17α,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
ACETASOL HC
ACTICO МИХАИЛRT
Acticort
Acticort®|Efmody®|Plenadren®
Aeroseb HC
Aeroseb-HC
Alacort
Ala-cort
Ala-scalp
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort-HC
ANUGESIC HC
Anusol HC
ANUSOL PLUS HC
ANUSOL SOOTHING RELIEF
Anusol-HC
Aquacort
Aquanil HC
Balneol-HC
Barseb HC
Basan-corti
Beta-HC
b-HC
CaldeCORT spray
CALMURID HC
CANESTEN HC
Cetacort
Chronocort
CIPRO HC
Clear aid
Cleiton
Cobadex
Colocort
Compound F
CORLAN
Cor-oticin
Cortanal
Cor-tar-quin
Cort-dome
Cortef
CORTENEM
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisolonum
Cortisporin
Cortisporin otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cort-quin
CORTRIL
Cremesone
Cremicort-H
Cutisol
DAKTACORT
DAKTACORT HYDROCORT
Delacort
DERMA CARE HYDROCORT
Dermacort
Derm-aid
DERMASPRAY DEMANG
Dermil
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
ECONACORT
Ef corlin
Efcorbin
Efcortelan
EFCORTELAN P
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
EURAX-HC
EURAX-HYDROCORT
Evacort
EXE-CORT
Ficortril
Fiocortril
Flexicort
Foille insetti
Genacort
GERMOLOIDS HC
Glycort
GREGODERM
gyno-Cortisone
HC
|
HC #1
HC #4
HC (HYDROCORTISONE)
HC45
H-Cort
Heb cort
Heb-cort
Hi-cor
Hidalone
hidro-Colisona
Hidrocortisona
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
hydro-Adreson
hydro-Colisona
Hydrocort
HYDROCORT IN CALAMINE OILY
HYDROCORT IN CETOMACROGOL FOR A
HYDROCORT IN WTE SOFT PARAF
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone butyrate
Hydrocortisone free alcohol
Hydrocortisone in absorbase
Hydrocortisone sodium phosphate
Hydrocortisone valerate
Hydrocortisone, (11 alpha)-isomer
Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer
Hydrocortisonum
Hydrocortistab
Hydrocortisyl
HYDROCORTONE
HYDRODERM
HYDRODERM HC
hydro-RX
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone lotion
Idrocortisone
Incortin-H
Incortin-hydrogen
JUNGLE FOR
Kendall's compound F
Komed HC
Kyypakkaus
Lacticare HC
Lacticare-HC
Lactisona
Locoid
Lubricort
Maintasone
Medicort
Meusicort
Micort-HC
Mildison
MILDISON LIPOCREAM
Milliderm
neo-Cort-dome
neo-Cortef
Neosporin-H ear
Nogenic HC
NSC-10483
Nutracort
NYBADEX
Nystaform-HC
Ophthocort
Optef
Otalgine
Otic-neo-cort-dome
Otobiotic
Otocort
OTOSEPTIL
Otosone-F
OTOSPORIN
Pediotic suspension
Penecort
PERINAL
Permicort
Plenadren
Polcort H
Preparation H hydrocortisone cream
Prepcort
Prestwick_265
Prevex HC
Proctocort
PROCTOCREAM HC
Proctofoam
PROCTOFOAM HC
PROCTOSEDYL
Protocort
QUINOCORT
Racet
Rectoid
Reichstein's substance m
Remederm HC
Sanatison
Scalpicin capilar
Schericur
Scheroson F
SENTIAL HC
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral hydrocort
Tarcortin
Terra-cortril
TERRA-CORTRIL NYSTATIN
Texacort
Timocort
TIMODINE
Topicort
TOPISONE
Transderma H
Traumaide
TRI-CICATRIN
U-cort
Uniderm
UNIROID
UNIROID HC
Vioform-hydrocortisone
VoSol HC
Vytone
XYLOPROCT
Zenoxone
β-HC
|
|
40 |
|
Cytarabine |
Approved, Investigational |
Phase 4 |
|
147-94-4 |
6253 |
Synonyms:
(beta-D-Arabinofuranosyl)cytosine
1-Arabinofuranosylcytosine
1-b-D-Arabinofuranosylcytosine
1beta -Arabinofuranasylcytosine
1-beta -D-Arabinofaranosylcytosine
1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1beta -D-Arabinofuranosylcytosine
1-beta -D-Arabinofuranosylcytosine
1beta -D-Arabinosylcytosine
1beta-Arabinofuranasylcytosine
1-beta-D-Arabinofaranosylcytosine
1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1beta-D-Arabinofuranosylcytosine
1-beta-D-Arabinofuranosylcytosine
1-beta-D-Arabinofuranosyl-cytosine
1-beta-D-Arabinofuranosylcytosine, cytosine arabinoside
1beta-D-Arabinosylcytosine
1-beta-D-Arabinosylcytosine
1-beta-D-Arabinosyl-cytosine
1-Β-D-arabinofuranosylcytosine
2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine
4-Amino-1-b-D-arabinofuranosyl-2(1H)-pyrimidinone
4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
4-Amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one
4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
Alexan
ALEXAN 100
AR3
Ara C
Arabinocytidine
Arabinocytosine
Arabinofuranosylcytosine
Arabinoside C
Arabinoside, cytosine
ARABINOSYL CYTOSINE
Arabinosylcytosine
Arabitin
AraC
Ara-C
Aracytidine
ARA-CYTIDINE
Aracytin
Aracytine
Arafcyt
beta Ara C
beta -Arabinosylcytosine
beta -Cytosine arabinoside
beta -D-Arabinosylcytosine
beta-Ara c
|
beta-Arabinosylcytosine
beta-Cytosine arabinoside
beta-D-Arabinosylcytosine
Citarabina
Citarabina [INN-Spanish]
Cytarabin
Cytarabina
Cytarabine
Cytarabine hydrochloride
Cytarabine liposome
Cytarabine liposome injection
Cytarabinoside
Cytarabinum
Cytarabinum [INN-Latin]
Cytarbel
Cytonal
Cytosar
Cytosar u
Cytosar-u
CytosarU
Cytosine 1-beta-D-arabinofuranoside
Cytosine arabinofuranoside
Cytosine arabinose
Cytosine arabinoside
Cytosine beta-D-arabinofuranoside
Cytosine beta-D-arabinoside
Cytosine, beta -D-arabinoside
Cytosine, beta-D-arabinoside
Cytosine-1-b-D-arabinofuranoside
Cytosine-1-beta-D-arabinofuranoside
Cytosine-1-beta-D-arabinofuranoside hydrochloride
Cytosine-1-β-D-arabinofuranoside
Cytosinearabinoside
Cytosine-b-D-arabinofuranoside
Cytosine-beta -arabinoside
Cytosine-beta -D-arabinofuranoside
Cytosine-beta-arabinoside
Cytosine-beta-D-arabinofuranoside
Cytosine-β-D-arabinofuranoside
Depocyt
Depocyt (liposomal)
Depocyte
Erpalfa
Hydrochloride, cytarabine
Iretin
NSC-287459
Spongocytidine
Tarabine
TARABINE PFS
U-19920
Udicil
|
|
41 |
|
Doxepin |
Approved, Investigational |
Phase 4 |
|
1668-19-5 |
667468 667477 |
Synonyms:
[<sup>11</sup>C]-doxepin
3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine
Adapin
Apo doxepin
Apo-doxepin
ApoDoxepin
Aponal
Curatin
Deptran
Deptran®|P-3693A|Sinequan®
Desidox
Doneurin
Doxepia
DOXEPIN
Doxepin beta
Doxepin Hcl
Doxepin hydrochloride
Doxepin hydrochloride, cis-trans isomer mixture (approximately 1:5)
Doxepin RPH
Doxepin, Hydrochloride
|
Doxepina
Doxepina [INN-Spanish]
Doxepine
Doxepin-RPH
Doxepinum
Doxepinum [INN-Latin]
Espadox
Hydrochloride, doxepin
Mareen
Novo doxepin
Novo-doxepin
P-3693A
Prudoxin
Quitaxon
SINEPIN
Sinequan
Sinquan
Triadapin
Xepin
Zonalon
|
|
42 |
|
Temazepam |
Approved, Investigational |
Phase 4 |
|
846-50-4 |
5391 |
Synonyms:
3 Hydroxydiazepam
3-Hydroxydiazepam
AHP brand OF temazepam
Alphapharm brand OF temazepam
apo Temazepam
apo-Temazepam
Apotex brand OF temazepam
CT Arzneimittel brand OF temazepam
CT-Arzneimittel brand OF temazepam
Dasuen
Desitin brand OF temazepam
Euhypnos
Gen temazepam
Genopharm brand OF temazepam
Genpharm brand OF temazepam
Gen-temazepam
Hydroxydiazepam
ICN brand OF temazepam
Katwijk brand OF temazepam
KENTEPAM
Knoll brand OF temazepam
Levanxol
Mallinckrodt brand OF temazepam
Methyloxazepam
N-Methyloxazepam
Nocturne
Norkotral tema
Normison
Normitab
Nortem
Norton brand OF temazepam
Novartis brand OF temazepam
novo Temazepam
Novopharm brand OF temazepam
|
novo-Temazepam
NSC-246303
Nu pharm brand OF temazepam
Nu temazepam
Nu-pharm brand OF temazepam
Nu-temazepam
Orion brand OF temazepam
Oxydiazepam
Pfizer brand 1 OF temazepam
Pfizer brand 2 OF temazepam
Pharmascience brand OF temazepam
Planum
PMS Temazepam
PMS-Temazepam
Pronervon T
Remestan
RER603
Restoril
RESTORIL (TN)
Scheffler brand OF temazepam
Sigma brand OF temazepam
Signopam
Tema, norkotral
TEMAZ
Temaze
Temazep von CT
Temazepam
TEMAZEPAM CIV
Temtabs
Tenox
Von CT, temazep
WY-3917
Wyeth brand OF temazepam
|
|
43 |
|
Amprenavir |
Approved, Investigational |
Phase 4 |
|
161814-49-9 |
65016 |
Synonyms:
(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate
(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamic acid
(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulphonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate
(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulphonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamic acid
141 W94
141W94
Agenerase
AMP
Amprenavir
Amprénavir
Amprenavirum
|
AMV
APV
Glaxo wellcome brand OF amprenavir
GlaxoSmithKline brand OF amprenavir
J05AE05
KVX-478
Prozei
Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate
Vertex
Vertex VX478
VX-478
|
|
44 |
|
Aminosalicylic acid |
Approved |
Phase 4 |
|
65-49-6 |
4649 |
Synonyms:
2-HYDROXY-4-aminobenzoate
2-HYDROXY-4-aminobenzoIC ACID
4 Aminosalicylic acid
4-amino-2-hydroxybenzoic acid
4-Aminosalicylate
4-Aminosalicylic acid
4-ASA
Acid, aminosalicylic
Alumino 4 aminosalicylic acid
Alumino-4-aminosalicylic acid
Amino-pas
Aminosalicylate
Aminosalicylate sodium
Aminosalicylic acid
APAS
p Aminosalicylic acid
p Aminosalicylic acid monolithium salt
p Aminosalicylic acid monopotassium salt
|
p Aminosalicylic acid monosodium salt
p-Aminosalicylate
p-Aminosalicylic acid
p-Aminosalicylic acid monolithium salt
p-Aminosalicylic acid monopotassium salt
p-Aminosalicylic acid monosodium salt
p-Aminosalicylic acid, aluminum (2:1) salt
p-Aminosalicylic acid, calcium (2:1) salt
p-Aminosalicylic acid, monosodium salt, dihydrate
Pamisyl
Para aminosalicylic acid
Para-amino salicylate
Para-amino salicylic acid
Para-aminosalicylic acid
PAS
Paser
PASK
Rezipas
|
|
45 |
|
Ketoconazole |
Approved, Investigational |
Phase 4 |
|
65277-42-1, 142128-57-2 |
47576 3823 638701 |
Synonyms:
(+-)-cis-1-Acetyl-4-(P-((2-(2,4-dichlorophenyl)-2-(imidazol-1- ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
(2S,4R)-1-Acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
(2S,4R)-ketoconazole|COR-003|COR003|Recorlev®
1-[4-[4-[[2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL]METHOXY]PHENYL]-1-PIPERAZINYL]ETHANONE
1-ACETYL-4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
ABBR KTC
cis-1-Acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H- imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-ketoconazol
COR003
COR-003
DAKTARIN GOLD
DAKTARIN INTENSIV
DANDRAZOL
DANDRID
EXTINA
Fungarest
Fungoral
J02AB02
Janssen brand OF ketoconazole
KETOCONAZOL
Ketoconazole
|
Ketoconazole janssen brand
KETOCONAZOLUM
Ketoderm
Ketoisdin
KETOPINE
KETOSIDIN
KETOZOLE
LEVOKETOCONAZOLE
Nizoral
NIZORAL A-D
Nizoral®|R-41400
NIZORELLE
NSC 317629
NSC-317629
Orifungal m
Panfungol
Piperazine
R-41400
SID456469
Xolegel
|
|
46 |
|
Foscarnet |
Approved |
Phase 4 |
|
63585-09-1, 4428-95-9 |
3415 |
Synonyms:
Carboxyphosphonate
Carboxyphosphonic acid
Dihydroxyphosphinecarboxylic acid oxide
Disodium salt, foscarnet
Foscarmet
FOSCARNET
Foscarnet barium (2:3) salt
Foscarnet calcium (2:3) salt
Foscarnet disodium salt
Foscarnet magnesium (2:3) salt
Foscarnet manganese (2+) (2:3) salt
Foscarnet sodium
Foscarnet sodium hexahydrate
Foscarnet trilithium salt
Foscarnet tripotassium salt
Foscarnet trisodium salt
|
Foscavir
Hexahydrate, foscarnet sodium
J05AD01
Phgosphonocarboxylic acid
PHOSPHONOCARBOXYLIC ACID
Phosphonoformate
Phosphonoformate, trisodium
Phosphonoformic acid
Phosphonomethanoate
Phosphonomethanoic acid
Sodium hexahydrate, foscarnet
Sodium, foscarnet
Trilithium salt, foscarnet
Tripotassium salt, foscarnet
Trisodium phosphonoformate
Trisodium salt, foscarnet
|
|
47 |
|
Clarithromycin |
Approved |
Phase 4 |
|
81103-11-9 |
84029 |
Synonyms:
6-O-METHYL ERYTHROMYCIN
6-O-Methylerythromycin
6-O-Methylerythromycin a
A-56268
ABBOTT-56268
Biaxin
BIAXIN XL
BIAXIN XL PAC
CAM
CLA
CLARIE XL
CLARITHROMYCIN
CLARITHROMYCIN EXTENDED RELEASE
CLARITHROMYCIN IDENTITY
Clarithromycina
Clarithromycine
|
Clarithromycinum
Claritromicina
CLAROSIP
Clathromycin
FEBZIN XL
KLARICID
KLARICID 500
KLARICID ADULT
KLARICID I.V.
KLARICID PAED
KLARICID XL
MYCIFOR XL
PREVPAC
TE-031
XETININ XL
ZECLAR
|
|
48 |
|
Itraconazole |
Approved, Investigational |
Phase 4 |
|
84625-61-6 |
55283 |
Synonyms:
ITC
ITCZ
Itraconazol
ITRACONAZOLE
Itraconazole janssen brand
Itraconazolum
ITRAZOLE
Itrizole
ITZ
Janssen brand OF itraconazole
Janssen cilag brand OF itraconazole
|
Janssen-cilag brand OF itraconazole
ONMEL
Oriconazole
Orungal
R-51211
SPORANOS
Sporanox
SPORANOX I.V.
SPORANOX-PULSE
TOLSURA
|
|
49 |
|
Valganciclovir |
Approved, Investigational |
Phase 4 |
|
175865-60-8 |
64147 |
Synonyms:
Cymeval
Ganciclovir L-valyl ester
L-Valine, ester with ganciclovir
RO-1079070/194
RS-079070-194
|
Valcyt
Valcyte
VALGANCICLOVIR
Valganciclovir hydrochloride
|
|
50 |
|
Magnesium sulfate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
7487-88-9 |
|
Synonyms:
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulphate
|
magnesium(II) sulfate
Magnesiumsulfat
MgSO4
|
|
Interventional clinical trials:
(show top 50)
(show all 5231)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda |
Unknown status |
NCT00674921 |
Phase 4 |
cotrimoxazole;Placebo |
2 |
A Pilot Study of Highly Active Antiretroviral Therapy Using Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Antiretroviral Naive HIV-Infected Subjects |
Unknown status |
NCT00740064 |
Phase 4 |
Raltegravir and Abacavir/Lamivudine |
3 |
Efecto de la Isoprinosina en Pacientes Con infección Por VIH y Carga Viral Entre > 50 y < 200 Copias/mL de la Unidad de atención de PVV Del Hospital Enrique Garcés en Quito, Ecuador Durante el año 2019. |
Unknown status |
NCT03883334 |
Phase 4 |
Metisoprinol |
4 |
Multicenter, Open, Pilot Clinical Trial Aimed to Compare the Efficacy of RAL1200 QD vs DRV-cb 800-150 QD Both in Combination With TAF/FTC in Patients With HIV Infection and CD4 Count Under 200 Cells/microL |
Unknown status |
NCT03842488 |
Phase 4 |
Experimental: RAL QD;Active comparator: DRV/cb |
5 |
Open Label Phase 4, 48 Week Pilot Study of the Antiviral Efficacy and Tolerability of the Combination of Isentress™ and ReyatazTM When Substituted for Current Antiviral Regimen in Patients With Viral Suppression But Who Are Experiencing Adverse Events Related to Their Current Antiviral Regimen. |
Unknown status |
NCT00751153 |
Phase 4 |
Raltegravir and Atazanavir |
6 |
An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of a Fixed-Dose Combination of Abacavir 600 mg/Lamivudine 300 mg Once-Daily in Combination With Atazanavir 300 mg + Ritonavir 100 mg Once-Daily in Antiretroviral-Naïve HIV-1 Infected Subjects With Continuing Evaluation of Abacavir/Lamivudine Plus Atazanavir 400 mg for Maintenance Over an Additional 48 Weeks |
Unknown status |
NCT00426296 |
Phase 4 |
atazanavir (Reyataz);ritonavir (Norvir) |
7 |
A Phase IV, Multicenter, Open and Randomized Study to Assess the Impact of the Change From Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With Type 1 HIV Infection. InSTINCT Study |
Unknown status |
NCT04076423 |
Phase 4 |
Dual Therapy;Triple therapy |
8 |
Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study |
Unknown status |
NCT03732625 |
Phase 4 |
Raltegravir |
9 |
Impact of HIV-1 and Aging on Mucosal Vaccine Responses |
Unknown status |
NCT03729778 |
Phase 4 |
|
10 |
Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population (ProPositive Study) |
Unknown status |
NCT03682939 |
Phase 4 |
|
11 |
Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism in ARV-naive HIV-infected Subjects |
Unknown status |
NCT00759070 |
Phase 4 |
Tenofovir + emtricitabine + efavirenz;Tenofovir + emtricitabine + lopinavir/ritonavir |
12 |
Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients Receiving Protease Inhibitors: a Randomized, Prospective, Controlled Pilot Study. |
Unknown status |
NCT00843661 |
Phase 4 |
ezetimibe;fenofibrate;pravastatin |
13 |
A Randomized Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication |
Unknown status |
NCT00840762 |
Phase 4 |
|
14 |
Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring |
Unknown status |
NCT00836212 |
Phase 4 |
Reducing dose of Lopinavir;Reducing dose of efavirenz |
15 |
Efficacy of Pentoxyfylline Addition to a Treatment Scheme Based on Interferon Alpha and Ribavirin on Hepatitis C Virus Coinfected HIV Patients, Considering Interleukin 28B Polymorphism rs12979860 |
Unknown status |
NCT02008214 |
Phase 4 |
Pentoxifylline;Placebo |
16 |
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings |
Unknown status |
NCT00124358 |
Phase 4 |
Buprenorphine |
17 |
Research on the Antiretroviral Therapy and Immune Reconstitution on Chinese HIV/AIDS Patients |
Unknown status |
NCT00872417 |
Phase 4 |
first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT);second line ARV therapy (3TC+TDF+LPV/RTV) |
18 |
MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) |
Unknown status |
NCT00122226 |
Phase 4 |
Lopinavir/ritonavir + zidovudine + lamivudine;Lopinavir/ritonavir + nevirapine |
19 |
A Phase IV, Open-label, Multicenter and Single-arm on the Immunogenicity of Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017 |
Unknown status |
NCT03626467 |
Phase 4 |
|
20 |
Pharmacokinetic Interaction Between Coartem® and Either Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients |
Unknown status |
NCT00620438 |
Phase 4 |
Lumefantrine-artemether and nevirapine;lumefantrine-artemether and efavirenz;Lumefantrine-artemether and rifampicin |
21 |
A Phase IV, Open-Label, Randomized Study to Compare the Efficacy and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) for 96 Weeks in the Treatment of HIV-1 Infected Subjects Who Are Antiretroviral Therapy Naive |
Unknown status |
NCT00005017 |
Phase 4 |
Ritonavir;Abacavir sulfate;Amprenavir;Efavirenz;Lamivudine;Stavudine |
22 |
A Randomized, Open-Label, Study of Nelfinavir or Efavirenz in HIV-1 Infected, Antiretroviral Naive Patients |
Unknown status |
NCT00005000 |
Phase 4 |
Nelfinavir mesylate;Efavirenz;Lamivudine;Keyhole-Limpet Hemocyanin;Stavudine;Zidovudine;Didanosine |
23 |
Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen (B/F/TAF) |
Unknown status |
NCT04054089 |
Phase 4 |
Bictegravir 50 MG / Emtricitabine 200 MG / Tenofovir Alafenamide 25 MG [Biktarvy];dolutegravir 50 mg / lamivudine 300 mg |
24 |
Efficacy and Safety of an Initial Regimen Raltegravir (RAL) + Lamivudine/Abacavir Fixed-Dose Combination (3TC/ABC FDC) for 48 Weeks in ART-naïve, HIV/TB Co-Infected Adult Subjects Receiving Rifabutin-containing, 1-line Anti-TB Therapy |
Unknown status |
NCT01059422 |
Phase 4 |
Raltegravir; Abacavir/Lamivudine |
25 |
A Phase IV Multicenter Study of the Efficacy and Safety of 48-Week Induction Treatment With TRIZIVIR (Abacavir 300 Mg/Lamivudine 150 Mg/Zidovudine 300 Mg Combination Tablet BID) With Efavirenz (600 Mg QD) Followed by 48-Week Randomized, Open-Label, Maintenance Treatment With TRIZIVIR With or Without Efavirenz in HIV-1 Infected Antiretroviral Therapy Naive Subjects |
Unknown status |
NCT00011895 |
Phase 4 |
Abacavir sulfate, Lamivudine and Zidovudine;Efavirenz |
26 |
Effects of Antihypertensive Treatment on Cardiac Remodelling and Metabolic Profile in HIV Infected Patients: Randomized Longitudinal Study With Candesartan Versus Lercanidipine |
Unknown status |
NCT00564057 |
Phase 4 |
candesartan;lercanidipine |
27 |
An Open-label, Randomised Pilot Study Comparing the Efficacy, Safety and Tolerability of Raltegravir With Protease Inhibitor-based Therapy in Treatment-naïve, HIV/Hepatitis C Co-infected Injecting Drug Users Receiving Methadone |
Unknown status |
NCT01105611 |
Phase 4 |
Raltegravir;Atazanavir/Ritonavir |
28 |
SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model |
Unknown status |
NCT00241930 |
Phase 4 |
|
29 |
Pilot, Open-label, Randomized, Single-center Study to Asses a Simplification Strategy From Protease Inhibitors to Raltegravir: Once Daily Isentress (ODIS) |
Unknown status |
NCT00941083 |
Phase 4 |
Raltegravir (Use RAL as a simplification strategy) |
30 |
Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy in Brazil: a "Real Life" Study |
Unknown status |
NCT01049685 |
Phase 4 |
First-line Antiretroviral Therapy |
31 |
Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI) Treated With Multitarget Antiviral Therapy (MT-ART) |
Unknown status |
NCT04225325 |
Phase 4 |
|
32 |
A Prospective, Single Arm, Open-label 96 Week Observational Trial of the Tolerability, Adherence and Efficacy of a Dolutegravir/Abacavir/Lamivudine Single Tablet Regimen in HIV-1 Antibody Positive People Living With HIV With a History of Injection Drug Use Switching From Existing ART or Starting Treatment After Discontinuation of ART |
Unknown status |
NCT02659761 |
Phase 4 |
dolutegravir/abacavir/lamivudine |
33 |
Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus |
Unknown status |
NCT00797030 |
Phase 4 |
cyclosporine and sodium carboximethycellulose;sodium carboximethycellulose |
34 |
Effectiveness of Booster Vaccination With 1 or 2 Doses of Hepatitis A Vaccine Among HIV-infected Patients During an Ongoing Outbreak in Taiwan |
Unknown status |
NCT03855176 |
Phase 4 |
Vaqta Injectable Product |
35 |
Empiric Treatment for Suspected Acute HIV Infection in the Emergency Department |
Unknown status |
NCT03711253 |
Phase 4 |
Bictegravir 50mg+Tenofovir AF 25 mg+emtricitabine 200 mg |
36 |
Integral Research of the Managing and Treatment of the Infection With Human Immunodeficiency (VIH) /Human Immunodeficiency Syndrome(SIDA) Co-infection With Latent Tuberculosis Infection. A Multidisciplinary and Interinstitucional Approach |
Unknown status |
NCT01875952 |
Phase 4 |
Isoniazid |
37 |
Prospective Pilot Study of the Efficacy, Safety and Tolerability of Bictegravir-Based HIV ART Same-Day Treatment Evaluations (B-HASTE) |
Unknown status |
NCT04249037 |
Phase 4 |
bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF);Standard initiation of antiretroviral therapy (ART) |
38 |
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed |
Unknown status |
NCT04132674 |
Phase 4 |
Bictegravir/emtricitabine/tenofovir alafenamide |
39 |
Study of the Immunogenicity and Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Adults |
Unknown status |
NCT03041051 |
Phase 4 |
|
40 |
Boosted PI VS. NNRTI Based Therapy as Initial Treatment for HIV-1 Infected Patients With Advanced Disease |
Unknown status |
NCT00162643 |
Phase 4 |
zidovudine+lamivudine+lopinavir/ritonavir;zidovudine + lamivudine + efavirenz |
41 |
Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study) |
Unknown status |
NCT00120419 |
Phase 4 |
mycophenol mofetil (MMF, Cellcept®) 500 mg BID |
42 |
Immune Reconstitution in Severely Immunosuppressed Antiretroviral-naive HIV-1-Infected Patients (<100 CD4+ T Cells/μL) Taking Antiretroviral Regimens Based on Dolutegravir or Ritonavir-boosted Darunavir (the Advanz-4 Trial). |
Unknown status |
NCT02337322 |
Phase 4 |
Dolutegravir;Darunavir/r |
43 |
A Randomised, Multi-Centre, Open-Label Study in Well-Controlled Treatment-Experienced HIV-Infected Patients to Assess Compliance With a Once-Daily Regimen of Lamivudine, Efavirenz and Didanosine Versus Continuation of Current Anti-Retroviral Regimen Delivered at Least Twice Daily |
Unknown status |
NCT00214435 |
Phase 4 |
once daily minimum 3-drug regimen of anti-retroviral medications |
44 |
Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B |
Unknown status |
NCT03120494 |
Phase 4 |
Emtricitabine and Tenofovir |
45 |
A Randomised Controlled Trial of a Strategy of Switching to Boosted PI Monotherapy Versus Continuing Combination ART for the Long-term Management of HIV-1 Infected Patients Who Have Achieved Sustained Virological Suppression on HAART |
Unknown status |
NCT01230580 |
Phase 4 |
Protease Inhibitor;Standard-of-care Antiretroviral therapy |
46 |
Pilot Study of the Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection |
Unknown status |
NCT01343225 |
Phase 4 |
atripla;darunavir ritonavir raltegravir |
47 |
Phase IV, Randomized, Open Label, Crossover, Intervention Trial to Investigate the Effect of the Switch of Lopinavir/Ritonavir to Raltegravir on Endothelial Function, Chronic Inflammation, Immune Activation and HIV Replication <50 Copies/ml |
Unknown status |
NCT01453933 |
Phase 4 |
raltegravir |
48 |
Entecavir Intensification for Persistent Hepatitis B Virus (HBV) Viremia in HIV-HBV Infection |
Completed |
NCT00662545 |
Phase 4 |
Entecavir with continued standard of care antiretroviral therapy;continued standard of care with tenofovir in addition to emtricitabine or lamivudine |
49 |
Efficacy and Safety of Switching From AZT to Tenofovir |
Completed |
NCT00647244 |
Phase 4 |
Tenofovir disoproxil fumarate;Abacavir |
50 |
Long-term Safety of Subjects Continuing Dolutegravir After Participation in Clinical Studies of Dolutegravir in Russian Federation |
Completed |
NCT03314064 |
Phase 4 |
Dolutegravir 50 mg |
|